Anti-Mi-2 Ab

In the diagnosis of dermatomyositis, the presence of Mi-2 antibodies is a positive marker. They are classically associated with the "typical" form of the disease, which often responds better to treatment and is associated with a reduced risk of certain complications such as cancer or severe lung disease.